Sign In
Buy CAH
$195.85
+0.97 (+0.498%)
At Close: Jun 03, 2026
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
10:41am, Friday, 07'th Nov 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should Value Investors Buy Cardinal Health (CAH) Stock?
10:41am, Friday, 07'th Nov 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Is Cardinal (CAH) a Buy as Wall Street Analysts Look Optimistic?
10:31am, Friday, 07'th Nov 2025
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)
01:46pm, Thursday, 06'th Nov 2025
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
10:16am, Thursday, 06'th Nov 2025
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cardinal Health: Quiet Transformation, Clear Buy
11:45am, Wednesday, 05'th Nov 2025
Cardinal Health (CAH) is evolving into a specialty-focused healthcare leader, leveraging acquisitions and managed services for higher profitability and efficiency. CAH's financials show strong gross p
Grants are a part of $5 million commitment from Cardinal Health Foundation and awarded by the National Association of Free & Charitable Clinics Grants are a part of $5 million commitment from Cardinal
Cardinal Health Board of Directors Approves Quarterly Dividend
04:45pm, Tuesday, 04'th Nov 2025
DUBLIN, Ohio , Nov. 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital
Cardinal Health completes acquisition of Solaris Health
08:30am, Monday, 03'rd Nov 2025
Adds the country's leading urology MSO with over 750 providers to Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance and brings Cardinal Health's MSO platforms to ~3,000 pr
Cardinal Health CEO says Obamacare subsidies extension under review 'every single day'
10:01pm, Sunday, 02'nd Nov 2025
Cardinal Health CEO Jason Hollar discusses medication affordability, the Obamacare subsidies battle and more on 'The Claman Countdown.' #fox #media #us #usa #new #news #foxbusiness #healthcare #medici
Oppenheimer Asset Management Inc. Makes New Investment in Cardinal Health, Inc. $CAH
05:28am, Sunday, 02'nd Nov 2025
Oppenheimer Asset Management Inc. acquired a new stake in shares of Cardinal Health, Inc. (NYSE: CAH) during the undefined quarter, according to its most recent Form 13F filing with the Securities and
Best Dividend Aristocrats For November 2025
10:25am, Saturday, 01'st Nov 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed SPY in 2025, with a 6.27% YTD gain versus SPY's 17.8%. Despite overall underperformance, select Aristocrats like CAT, CAH, CHRW
Healthcare Stocks To Follow Today – October 30th
05:08am, Saturday, 01'st Nov 2025
UnitedHealth Group, Cardinal Health, Johnson and Johnson, Intuitive Surgical, Hims and Hers Health, McKesson, and Baxter International are the seven Healthcare stocks to watch today, according to Mark
Cardinal Health Rallies As Strong Start To 2026 Fuels Higher Earnings Guidance
12:22pm, Thursday, 30'th Oct 2025
Cardinal Health Inc.'s (NYSE:CAH) stock surged on Thursday as the healthcare services company reported upbeat first-quarter 2026 earnings, with adjusted earnings of $2.55 per share, beating the conse
Cardinal Health, Inc. (CAH) Q1 2026 Earnings Call Transcript
11:56am, Thursday, 30'th Oct 2025
Cardinal Health, Inc. ( CAH ) Q1 2026 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Matt Sims - Vice President of Investor Relations Jason Hollar - CEO & Director Aaron Alt - Chief F
